These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 16542785)

  • 21. Defeating pathogen drug resistance: guidance from evolutionary theory.
    Pepper JW
    Evolution; 2008 Dec; 62(12):3185-91. PubMed ID: 18803686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The evolution of tuberculosis virulence.
    Basu S; Galvani AP
    Bull Math Biol; 2009 Jul; 71(5):1073-88. PubMed ID: 19172358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative genomics and the study of evolution by natural selection.
    Ellegren H
    Mol Ecol; 2008 Nov; 17(21):4586-96. PubMed ID: 19140982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A model of directional selection applied to the evolution of drug resistance in HIV-1.
    Seoighe C; Ketwaroo F; Pillay V; Scheffler K; Wood N; Duffet R; Zvelebil M; Martinson N; McIntyre J; Morris L; Hide W
    Mol Biol Evol; 2007 Apr; 24(4):1025-31. PubMed ID: 17272680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evolutionary genomics of host adaptation in vesicular stomatitis virus.
    Remold SK; Rambaut A; Turner PE
    Mol Biol Evol; 2008 Jun; 25(6):1138-47. PubMed ID: 18353798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Direct and correlated responses to selection in a host-parasite system: testing for the emergence of genotype specificity.
    Nidelet T; Kaltz O
    Evolution; 2007 Aug; 61(8):1803-11. PubMed ID: 17683424
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular basis of resistance to cytochrome bc1 inhibitors.
    Fisher N; Meunier B
    FEMS Yeast Res; 2008 Mar; 8(2):183-92. PubMed ID: 18093133
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting virulence: a new paradigm for antimicrobial therapy.
    Clatworthy AE; Pierson E; Hung DT
    Nat Chem Biol; 2007 Sep; 3(9):541-8. PubMed ID: 17710100
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evolution of carbohydrate antigens--microbial forces shaping host glycomes?
    Bishop JR; Gagneux P
    Glycobiology; 2007 May; 17(5):23R-34R. PubMed ID: 17237137
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Imperfect vaccines and the evolution of pathogens causing acute infections in vertebrates.
    Ganusov VV; Antia R
    Evolution; 2006 May; 60(5):957-69. PubMed ID: 16817536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative and evolutionary pharmacogenetics of ABCB1: complex signatures of positive selection on coding and regulatory regions.
    Wang H; Ding K; Zhang Y; Jin L; Kullo IJ; He F
    Pharmacogenet Genomics; 2007 Aug; 17(8):667-78. PubMed ID: 17622943
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genomic evolution in a virus under specific selection for host recognition.
    Pepin KM; Domsic J; McKenna R
    Infect Genet Evol; 2008 Dec; 8(6):825-34. PubMed ID: 18804189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predicting protein evolution in vitro by phage escape technology.
    Rohrbach AS; Dickerson TJ
    Mol Biosyst; 2009 Feb; 5(2):128-33. PubMed ID: 19156257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Group selection on population size affects life-history patterns in the entomopathogenic nematode Steinernema carpocapsae.
    Bashey F; Lively CM
    Evolution; 2009 May; 63(5):1301-11. PubMed ID: 19187254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adaptive value of sex in microbial pathogens.
    Michod RE; Bernstein H; Nedelcu AM
    Infect Genet Evol; 2008 May; 8(3):267-85. PubMed ID: 18295550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interrogating 11 fast-evolving genes for signatures of recent positive selection in worldwide human populations.
    Moreno-Estrada A; Tang K; Sikora M; Marquès-Bonet T; Casals F; Navarro A; Calafell F; Bertranpetit J; Stoneking M; Bosch E
    Mol Biol Evol; 2009 Oct; 26(10):2285-97. PubMed ID: 19578157
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular mechanisms of pathogenicity: how do pathogenic microorganisms develop cross-kingdom host jumps?
    van Baarlen P; van Belkum A; Summerbell RC; Crous PW; Thomma BP
    FEMS Microbiol Rev; 2007 Apr; 31(3):239-77. PubMed ID: 17326816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evolutionary paradigm of chloroquine-resistant malaria in India.
    Das A; Dash AP
    Trends Parasitol; 2007 Apr; 23(4):132-5. PubMed ID: 17280870
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impaired fitness of drug-resistant malaria parasites: evidence and implication on drug-deployment policies.
    Babiker HA; Hastings IM; Swedberg G
    Expert Rev Anti Infect Ther; 2009 Jun; 7(5):581-93. PubMed ID: 19485798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.